Published in Lancet on January 20, 1979
Hepatotrophic effects of FK506 in dogs. Transplantation (1991) 2.39
Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A (1994) 2.35
The hepatotropic influence of cyclosporine. Surgery (1990) 2.27
Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest (1988) 2.22
Augmentation of rat liver regeneration by FK 506 compared with cyclosporin. Lancet (1989) 2.01
Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver. Surg Gynecol Obstet (1980) 1.72
Extraction and partial purification of a hepatic stimulatory substance in rats, mice, and dogs. Cancer Res (1987) 1.43
A fresh look at augmenter of liver regeneration in rats. Hepatology (1999) 1.32
Screening for candidate hepatic growth factors by selective portal infusion after canine Eck's fistula. Hepatology (1991) 1.30
Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene. Mol Med (1996) 1.16
Studies of the hepatotrophic qualities of FK 506 and CyA. Transplant Proc (1990) 1.14
Augmenter of liver regeneration: an important intracellular survival factor for hepatocytes. J Hepatol (2008) 1.04
The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functions. Hepatology (1997) 1.04
Hepatic regeneration and growth factors. J Surg Oncol Suppl (1993) 1.01
Insights on augmenter of liver regeneration cloning and function. World J Gastroenterol (2006) 1.01
Further steps of hepatic stimulatory substance purification. Dig Dis Sci (1991) 1.01
Induction of hepatocyte stimulating activity by T3 and appearance of the activity despite inhibition of DNA synthesis by adriamycin. Horm Metab Res (1984) 0.99
History of clinical transplantation. World J Surg (2000) 0.91
Effect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors. Hepatology (1992) 0.89
Regulation of liver size and regeneration: importance in liver transplantation. Transplant Proc (1988) 0.88
Prostaglandin E2 production during hepatic regeneration downregulates Kupffer cell IL-6 production. Ann Surg (1992) 0.87
Cholera toxin-sensitive GTP-binding protein-coupled activation of augmenter of liver regeneration (ALR) receptor and its function in rat kupffer cells. J Cell Physiol (2010) 0.85
The characterization and partial purification of hepatocyte proliferation factor. Ann Surg (1985) 0.85
Crystallization and preliminary crystallographic data for the augmenter of liver regeneration. Acta Crystallogr D Biol Crystallogr (1997) 0.83
Augmenter of liver regeneration. Fibrogenesis Tissue Repair (2012) 0.83
Further studies on hepatic stimulatory substance (SS) after partial hepatectomy. J Surg Res (1980) 0.79
Does hyperprolactinemia affect hepatic regeneration independent of sex steroids? J Lab Clin Med (1988) 0.77
Effect of cyclosporine on hepatic energy status and on fructose metabolism after portacaval shunt in dog as monitored by phosphorus-31 nuclear magnetic resonance spectroscopy in vivo. Hepatology (1991) 0.77
Augmenter of liver regeneration (ALR) is a novel biomarker of hepatocellular stress/inflammation: in vitro, in vivo and in silico studies. Mol Med (2013) 0.75
The ripple effect of liver transplantation. Transplant Proc (1980) 0.75
Response of cultured hepatocytes to a hepatomitogen after initiation by conditioned medium or other factors. Cancer Res (1989) 0.75
NEW DEVELOPMENTS IN HEPATOLOGY. Nihon Shokaki Geka Gakkai Zasshi (1979) 0.75
The mother lode of liver transplantation, with particular reference to our new journal. Liver Transpl Surg (1998) 0.75
Hepatic Regeneration. Viewp Dig Dis (1979) 0.75
Isolation and Partial Purification of Hepatic Stimulatory Substance. Transplant Proc (1988) 0.75
Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab (1965) 14.95
A quantitative stereological description of the ultrastructure of normal rat liver parenchymal cells. J Cell Biol (1968) 4.95
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Regeneration of the liver. Gastroenterology (1959) 2.69
Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver. J Physiol (1975) 2.42
Liver regeneration in dogs: morphologic and chemical changes. J Surg Res (1978) 1.78
Hormonal control of rat liver regeneration. Gastroenterology (1979) 1.64
The effect of splanchnic viscera removal upon canine liver regeneration. Surg Gynecol Obstet (1978) 1.63
The regulation of cell growth. I. Identification and partial characterization of a DNA synthesis stimulating factor from the serum of partially hepatectomized rats. Biochim Biophys Acta (1973) 1.43
Mitotic activity and growth factors in the liver of the white rat. Exp Cell Res (1953) 1.30
Growth stimulation in the liver and tumour development following intraperitoneal injections of liver homogenates in the rat. Acta Pathol Microbiol Scand Suppl (1957) 1.27
LIVER CELL DAMAGE PRODUCED BY PORTACAVAL SHUNTS. Proc Soc Exp Biol Med (1965) 1.11
The presence of a mitosis inhibitor in the serum and liver of adult rats. Can J Biochem Physiol (1958) 1.03
The response of normal rat hepatocytes when exposed to humoral (regenerating) factor. J Surg Res (1972) 1.03
Insulin, glucagon, and the liver. Adv Enzyme Regul (1976) 1.02
The inhibition of the uptake of 3H-thymidine into liver DNA by the intraportal infusion of fresh serum after partial hepatectomy in the rat. Eur Surg Res (1974) 0.98
GROWTH INHIBITION BY SUBSTANCES IN LIVER. J Exp Med (1940) 0.97
Some observations on liver cell proliferation in the isolated perfused rat liver. Br J Exp Pathol (1974) 0.91
Evolution of liver transplantation. Hepatology (1982) 19.54
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90
Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49
Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32
A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16
Statins and hypercholesterolaemia: UK Standing Medical Advisory Committee guidelines. Lancet (1997) 4.14
Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12
Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12
Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99
Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99
Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
Hepatic Retransplantation. Transplant Proc (1985) 3.62
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet (1982) 3.52
Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49
Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Changes in blood coagulation. Arch Surg (1966) 3.22
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18
Renal transplantation in baboons under FK 506. Surgery (1989) 3.17
Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17
Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16
Liver transplantation before 1 year of age. J Pediatr (1987) 3.15
In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
De novo malignant tumors in organ transplant recipients. Transplant Proc (1971) 3.03
Experience with 150 liver resections. Ann Surg (1983) 3.01
A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
Death after transplantation; an analysis of sixty cases. Am J Med (1967) 2.99
Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98
Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95
Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95
Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev (1971) 2.94
Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92